Zhejiang Jingxin Pharmaceutical Hits Day Low of CNY 14.33 Amid Price Pressure

Zhejiang Jingxin Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 4.76% on March 23, 2026. The stock reached an intraday low of CNY 14.33, reflecting a challenging trading session. Over the past week, the stock has seen a significant decrease of 11.93%, while its performance over the past month shows a decline of 13.31%. In comparison, the China Shanghai Composite index fell by 3.63% today, indicating that Zhejiang Jingxin's performance was notably weaker than the broader market. Year-to-date, the stock has declined by 24.13%, contrasting with the index's drop of 3.92%. Despite these short-term challenges, the company has shown a positive annual return of 5.96% over the past year. Key financial metrics include a return on equity of 13.37% and a price-to-book ratio of 2.13. The company maintains a market capitalization of CNY 12,025 million, positioning it as a large-cap player in the pharmaceuticals and biotechnology sector.